FDA 483 - Fora Care, Inc - August 17, 2022

Fora Care, Inc. in Moorpark, CA, a manufacturer of blood glucose monitors, was inspected by the the FDA. The inspection revealed a significant deficiency in the documentation of corrective and preventive action (CAPA) activities. Specifically, the firm lacked documentation to verify or validate the effectiveness of its CAPA actions.